Telehealth companies are making significant strides in the healthcare industry by ramping up their advertising efforts and expanding into more complex areas of medicine. Initially known for providing low-stigma, easily accessible health products, these companies are now venturing into fields such
The recent study conducted by researchers at the Yong Loo Lin School of Medicine, National University of Singapore, and the Institute for Biostatistics and Informatics in Medicine and Aging Research, Rostock University Medical Center, delved into the promising potential of advanced AI tools,
Thermo Fisher Scientific is taking bold steps toward revolutionizing drug development through its innovative Accelerator Drug Development program. This strategy aims to streamline the complex process from preclinical stages to commercialization by integrating its contract research organization
The Blood and Cell Advocacy Register (BCAR) is a newly launched consortium that aims to revolutionize the development and commercialization of advanced therapy medicinal products (ATMPs). Formed in December 2024, BCAR brings together experts and organizations from the blood and cell industries to
Columbus Regional Health (CRH) has recently joined the Cleveland Clinic Connected program, an esteemed initiative aimed at enhancing healthcare quality by incorporating the expertise and best practices of Cleveland Clinic, a globally recognized healthcare institution. This partnership aims to
In a groundbreaking partnership aimed at revolutionizing the production processes for stem cell-based therapies, Mytos has joined forces with Aspen Neuroscience to enhance the manufacturing of autologous dopaminergic neuronal precursor cells (DANPCs). These cells are integral to Aspen’s ANPD001, an
